Transthyretin Genetic Testing
- 12 May 2021
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Cardiology
- Vol. 6 (7) , 849-850
Abstract
A 40-year-old woman recently participated in a research study that incidentally identified a pathogenic variant in the transthyretin (TTR) (OMIM 176300) gene. She was reported to have a single heterozygous nucleotide variant leading to substitution of serine for tyrosine at amino acid position 97 (Ser97Tyr, SNP rs267607161). The patient is of European descent, and her medical history was notable for carpal tunnel syndrome. She was asymptomatic from a cardiopulmonary standpoint. She reported no family history of amyloidosis, but her paternal grandfather died of heart disease at age 52 years. Her physical examination results showed a blood pressure of 112/76 mm Hg and heart rate of 79/min. Her cardiovascular examination results were unremarkable, with a jugular venous pressure of 5 cm H2O, no lower extremity edema, and normal heart sounds. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.Keywords
This publication has 8 references indexed in Scilit:
- Association of the V122I Transthyretin Amyloidosis Genetic Variant With Cardiac Structure and Function in Middle-aged Black AdultsJAMA Cardiology, 2021
- ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate UtilizationJournal of Cardiac Failure, 2019
- Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers ofTTRgene mutations*Amyloid, 2019
- Can 99mTc-Pyrophosphate Aid in Early Detection of Cardiac Involvement in Asymptomatic Variant TTR Amyloidosis?JACC: Cardiovascular Imaging, 2017
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- The Amyloidogenic V122I Transthyretin Variant in Elderly Black AmericansNew England Journal of Medicine, 2015
- Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective studyAmyloid, 2014
- Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variantEuropean Heart Journal, 2011